Jane Street’s Achillion Pharmaceuticals ACHN Stock Holding History

Jane Street’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-11,400	Closed	-$88K	–	4824
2016 Q1	$88K	Sell	11,400 -10,500	-48%	-$76.9K	﹤0.01%	3909
2015 Q4	$236K	Buy	+21,900	New	+$199K	﹤0.01%	3390
2015 Q3	–	Sell	-11,800	Closed	-$105K	–	4383
2015 Q2	$105K	Buy	+11,800	New	+$112K	﹤0.01%	3420
2015 Q1	–	Sell	-39,600	Closed	-$485K	–	3628
2014 Q4	$485K	Buy	+39,600	New	+$484K	﹤0.01%	1499

Jane Street's ACHN Position: Q1 2020 in Review

Jane Street sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 447,447 shares — an estimated $2.7M sold.

Jane Street first reported a position in ACHN in Q3 2013 and held it in 12 quarters. The position peaked at $2.7M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

Jane Street reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Jane Street sold 447,447 Achillion Pharmaceuticals shares in Q1 2020, an estimated $2.7M.
Jane Street first reported a position in Achillion Pharmaceuticals in Q3 2013 and held it in 12 quarters.
Jane Street's Achillion Pharmaceuticals position peaked at $2.7M in Q4 2019.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Jane Street's 13F filing for Q1 2020, filed 15 May 2020.